Delivery Order SPE2DB22D1017-SPE2DB25FG8BG
- Not listed
- The U.S. government awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Diltiazem 12HR ER 60 MG capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The $8,645.26 contract has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at fifty-two thousand six hundred sixty-eight dollars to Amerisourcebergen Drug Corporation for the supply of ninety capsules of 120mg Diltiazem extended release capsules. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of four days concluding on July 24, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order supports...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,397.91, is for the delivery of Diltiazem 12HR ER 60 MG capsules. The contract is not designated as a set-aside and has an ultimate completion date of May 21, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 100 units of Diltiazem 12HR ER 60 mg capsules, a cardiovascular medication, at a firm fixed price of $5,598.56. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. This...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty thousand seven hundred thirty dollars to Amerisourcebergen Drug Corporation for the supply of ninety capsules of 120mg Diltiazem HCl extended release capsules. As a major provider of pharmaceuticals and medical supplies to the Department of Defense through indefinite delivery/indefinite quantity contracts, this order for a common cardiovascular medication furthers DLA's mission to provide optimal logistics...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirteen thousand one hundred seventy dollars to Amerisourcebergen Drug Corporation for the supply of ninety capsules of 120mg Diltiazem HCl extended release capsules. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from July 24, 2023 through July 25, 2023. As the DLA supports procurement for the Department of Defense, this...
- This federal contract award was issued by the Defense Logistics Agency (DLA), an agency of the U.S. Department of Defense, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,469.27 firm-fixed-price delivery order is for the provision of Diltiazem 12HR ER 120 MG Capsules in 100-count packages, with a period of performance through May 21, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $9,235.12 contract is for the delivery of 4557723151 - Diltiazem 12HR ER 60 mg capsules in 100-count bottles. This delivery order falls under Amerisourcebergen Drug Corp's larger indefinite delivery contract with DLA, valued at up to $999,999,999.00 through...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $35,120 to Amerisourcebergen Drug Corporation for the supply of 90 packages containing 120mg extended release diltiazem capsules to support Defense Department requirements. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania within the period of performance between August 8-9, 2023. The Defense Logistics Agency routinely...
- The Defense Logistics Agency awarded a $52,680 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 90 packages containing 120mg extended release diltiazem capsules each. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 20, 2023 through September 21, 2023. As the DLA supports procurement for the Department of Defense, this delivery order is likely fulfilling medical supply...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG8BGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Diltiazem 12-hour extended-release 120 mg capsules (100-count units) with a ceiling value of $1,082.04. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, AmerisourceBergen Drug Corp leverages this comprehensive IDC to supply a broad range of pharmaceutical products and medical supplies to defense and federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability in managing complex federal medical procurement across multiple therapeutic domains, combined with its competitive performance record, positions it as a primary supplier within the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/24/25 |